• Je něco špatně v tomto záznamu ?

Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection

E. Varghese, SM. Samuel, Z. Sadiq, P. Kubatka, A. Liskova, J. Benacka, P. Pazinka, P. Kruzliak, D. Büsselberg,

. 2019 ; 20 (12) : . [pub] 20190620

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044738

Calcium (Ca2+) signaling and the modulation of intracellular calcium ([Ca2+]i) levels play critical roles in several key processes that regulate cellular survival, growth, differentiation, metabolism, and death in normal cells. On the other hand, aberrant Ca2+-signaling and loss of [Ca2+]i homeostasis contributes to tumor initiation proliferation, angiogenesis, and other key processes that support tumor progression in several different cancers. Currently, chemically and functionally distinct drugs are used as chemotherapeutic agents in the treatment and management of cancer among which certain anti-cancer drugs reportedly suppress pro-survival signals and activate pro-apoptotic signaling through modulation of Ca2+-signaling-dependent mechanisms. Most importantly, the modulation of [Ca2+]i levels via the endoplasmic reticulum-mitochondrial axis and corresponding action of channels and pumps within the plasma membrane play an important role in the survival and death of cancer cells. The endoplasmic reticulum-mitochondrial axis is of prime importance when considering Ca2+-signaling-dependent anti-cancer drug targets. This review discusses how calcium signaling is targeted by anti-cancer drugs and highlights the role of calcium signaling in epigenetic modification and the Warburg effect in tumorigenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044738
003      
CZ-PrNML
005      
20200113081236.0
007      
ta
008      
200109s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20123017 $2 doi
035    __
$a (PubMed)31226817
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Varghese, Elizabeth $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar. elv2007@qatar-med.cornell.edu.
245    10
$a Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection / $c E. Varghese, SM. Samuel, Z. Sadiq, P. Kubatka, A. Liskova, J. Benacka, P. Pazinka, P. Kruzliak, D. Büsselberg,
520    9_
$a Calcium (Ca2+) signaling and the modulation of intracellular calcium ([Ca2+]i) levels play critical roles in several key processes that regulate cellular survival, growth, differentiation, metabolism, and death in normal cells. On the other hand, aberrant Ca2+-signaling and loss of [Ca2+]i homeostasis contributes to tumor initiation proliferation, angiogenesis, and other key processes that support tumor progression in several different cancers. Currently, chemically and functionally distinct drugs are used as chemotherapeutic agents in the treatment and management of cancer among which certain anti-cancer drugs reportedly suppress pro-survival signals and activate pro-apoptotic signaling through modulation of Ca2+-signaling-dependent mechanisms. Most importantly, the modulation of [Ca2+]i levels via the endoplasmic reticulum-mitochondrial axis and corresponding action of channels and pumps within the plasma membrane play an important role in the survival and death of cancer cells. The endoplasmic reticulum-mitochondrial axis is of prime importance when considering Ca2+-signaling-dependent anti-cancer drug targets. This review discusses how calcium signaling is targeted by anti-cancer drugs and highlights the role of calcium signaling in epigenetic modification and the Warburg effect in tumorigenesis.
650    _2
$a zvířata $7 D000818
650    _2
$a antitumorózní látky $x farmakologie $x terapeutické užití $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a vápníková signalizace $x účinky léků $7 D020013
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a endoplazmatické retikulum $x účinky léků $x metabolismus $7 D004721
650    _2
$a lidé $7 D006801
650    _2
$a mitochondrie $x účinky léků $x metabolismus $7 D008928
650    _2
$a cílená molekulární terapie $x metody $7 D058990
650    _2
$a nádory $x farmakoterapie $x metabolismus $7 D009369
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Samuel, Samson Mathews $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar. sms2016@qatar-med.cornell.edu.
700    1_
$a Sadiq, Zuhair $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar. zuhairsadiq2018@u.northwestern.edu.
700    1_
$a Kubatka, Peter $u Department of Medical Biology and Department of Experimental Carcinogenesis, Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. kubatka@jfmed.uniba.sk.
700    1_
$a Liskova, Alena $u Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. alenka.liskova@gmail.com.
700    1_
$a Benacka, Jozef $u Faculty Health and Social Work, Trnava University, 918 43 Trnava, Slovakia. jozef.benacka@centrum.cz.
700    1_
$a Pazinka, Peter $u Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and Louise Pasteur University Hospital, 04022 Kosice, Slovakia. peter.pazinka@seznam.cz.
700    1_
$a Kruzliak, Peter $u Department of Internal Medicine, Brothers of Mercy Hospital, Polni 553/3, 63900 Brno, Czech Republic. peter.kruzliak@savba.sk. 2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, 65692 Brno, Czech Republic. peter.kruzliak@savba.sk.
700    1_
$a Büsselberg, Dietrich $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar. dib2015@qatar-med.cornell.edu.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 12 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31226817 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113081608 $b ABA008
999    __
$a ok $b bmc $g 1483007 $s 1083411
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 12 $e 20190620 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Možnosti archivace